Risk factors for the development of pedal edema in patients using pramipexole.
about
Renal dopaminergic system: Pathophysiological implications and clinical perspectivesSide effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacologyDopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study.Update on the use of pramipexole in the treatment of Parkinson's disease.Pramipexole and its extended release formulation for Parkinson's disease.
P2860
Risk factors for the development of pedal edema in patients using pramipexole.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Risk factors for the development of pedal edema in patients using pramipexole.
@en
type
label
Risk factors for the development of pedal edema in patients using pramipexole.
@en
prefLabel
Risk factors for the development of pedal edema in patients using pramipexole.
@en
P1433
P1476
Risk factors for the development of pedal edema in patients using pramipexole.
@en
P2093
David N Fisman
P304
P356
10.1001/ARCHNEUR.64.6.NOC60158
P577
2007-04-09T00:00:00Z